Valuation: Cellnovo

Market Cap 2.44M 2.18M 2M 1.82M 3.43M 229M 3.54M 24.06M 9.6M 122M 9.14M 8.95M 386M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.17M 10.21M 9.32M 17.56M 1.17B 18.12M 123M 49.08M 625M 46.76M 45.76M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-0.99%+1.67%+6.80%+46.09% 3,940B
+3.48%-12.89%-9.86%+767.39% 386B
+0.82%-11.15%-51.48%+3.36% 362B
+1.65%-0.24%-2.27%+58.24% 271B
-0.26%-14.22%+47.84%+160.36% 256B
-0.14%-13.39%+60.72%+347.61% 223B
+9.86%+71.21%-36.89%+875.12% 130B
-0.38%-3.00%-40.84%-18.47% 106B
-2.90%-4.37%-26.81%-59.12% 93.14B
Average +1.12%+1.36%-5.87%+242.29% 576.75B
Weighted average by Cap. -0.16%-0.11%+3.11%+124.77%

Financials

2018 2019 *
Net sales 3.32M 2.98M 2.72M 2.49M 4.68M 312M 4.83M 32.82M 13.09M 167M 12.47M 12.2M 526M -
Net income -15.94M -14.3M -13.07M -11.93M -22.47M -1.5B -23.18M -157M -62.79M -799M -59.83M -58.54M -2.52B -
Net Debt 10.02M 8.99M 8.22M 7.5M 14.13M 942M 14.57M 99.02M 39.48M 503M 37.62M 36.81M 1.59B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock